Skip to content

Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori

Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01264822
Enrollment
108
Registered
2010-12-22
Start date
2011-01-13
Completion date
2016-11-17
Last updated
2017-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive

Keywords

Rabeprazole Sodium, Helicobacter pylori, stomach neoplasms

Brief summary

To survey the grade of gastric MALT lymphoma after eradication of Helicobacter pylori

Interventions

DRUGRabeprazole Sodium

The following 3 drugs are taken orally at the same time twice daily for 7 days: rabeprazole sodium 10 mg, amoxicillin hydrate 750 mg, and clarithromycin 200 mg. The dose of clarithromycin may be properly increased as needed, although the upper limit is 400 mg twice daily. If Helicobacter pylori eradication with proton pump inhibitor, amoxicillin, and clarithromycin fails, the following 3 drugs will be taken at the same time twice daily for 7 days as an alternative treatment for adults: rabeprazole sodium 10 mg, amoxicillin hydrate 750 mg, and metronidazole 250 mg.

Sponsors

Eisai Co., Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* gastric low-grade mucosa-associated lymphoid tissue (MALT) lymphoma with Helicobacter pylori positive * The stages of MALT lymphoma are Lugano International Conference classification Stage I or II 1 and Wotherspoon grade 4 or 5

Exclusion criteria

* With diffuse large B-cell lymphoma * Have been treated to gastric mucosa-associated lymphoid tissue (MALT) lymphoma * Corresponding to contraindication of each drug

Design outcomes

Primary

MeasureTime frame
Response rate of gastric low-grade MALT lymphoma by eradication of Helicobacter pyloriEvery 3 months within the 1st year and every 6 months
Transition rate to secondary therapy for eradication of Helicobacter pyloriEvery 6 months within the 1st year and every 12 months as needed

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026